Form 4: Elanco Animal Health EVP & CFO Trades Shares
Insider Transaction Report
Elanco Animal Health Inc. reports a transaction by its EVP and CFO, Robert M. VanHimbergen, involving the acquisition of common stock.
Summary
- Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., acquired 15,336 shares of common stock on July 7, 2026.
- The acquisition was made at a price of $24.64 per share.
- Following this transaction, VanHimbergen beneficially owns 133,316 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction without providing new financial or strategic information.
Positives
- The EVP and CFO's direct acquisition of company stock can be interpreted as a positive signal of confidence in the company's future performance.
Future Outlook
No specific forward-looking statements or guidance are present in this filing.
Industry Context
StockSavvy.ai notes that insider transactions, such as this stock acquisition by a key executive, are closely watched by the market as potential indicators of management's view on the company's valuation and prospects within the animal health sector.
Stakeholder Impact
- Shareholders may view the CFO's stock purchase as a positive sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 07/07/2026 | Date of transaction (acquisition of common stock). |
| 07/09/2026 | Date of filing signature. |
Keywords
Elanco Animal Health, ELAN, Form 4, insider trading, stock acquisition, EVP and CFO, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.